IL132993A0 - Therapeutic agent for erection failure - Google Patents
Therapeutic agent for erection failureInfo
- Publication number
- IL132993A0 IL132993A0 IL13299398A IL13299398A IL132993A0 IL 132993 A0 IL132993 A0 IL 132993A0 IL 13299398 A IL13299398 A IL 13299398A IL 13299398 A IL13299398 A IL 13299398A IL 132993 A0 IL132993 A0 IL 132993A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic agent
- erection failure
- erection
- failure
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4029797P | 1997-05-29 | 1997-05-29 | |
| JP34413497 | 1997-11-29 | ||
| PCT/JP1998/002378 WO1998053819A1 (fr) | 1997-05-29 | 1998-05-29 | Agent therapeutique destine a traiter l'anerection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL132993A0 true IL132993A0 (en) | 2001-03-19 |
Family
ID=26577702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13299398A IL132993A0 (en) | 1997-05-29 | 1998-05-29 | Therapeutic agent for erection failure |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0992240A4 (xx) |
| KR (1) | KR20010012995A (xx) |
| CN (1) | CN1309561A (xx) |
| AU (1) | AU739417B2 (xx) |
| BR (1) | BR9809508A (xx) |
| CA (1) | CA2291256A1 (xx) |
| IL (1) | IL132993A0 (xx) |
| NO (1) | NO995823L (xx) |
| WO (1) | WO1998053819A1 (xx) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA9810766B (en) | 1997-11-28 | 1999-05-25 | Mochida Pharm Co Ltd | Novel compounds having cgmp-pde inhibitory activity |
| GT199900061A (es) * | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
| TWI223598B (en) * | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
| US6200591B1 (en) * | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
| WO2000032195A1 (fr) * | 1998-12-02 | 2000-06-08 | Mochida Pharmaceutical Co., Ltd. | Preparations destinees a etre administrees par voie uretrale |
| GB9828340D0 (en) * | 1998-12-22 | 1999-02-17 | Novartis Ag | Organic compounds |
| US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| JP2002539165A (ja) * | 1999-03-16 | 2002-11-19 | ペンテツク・フアーマシユーテイカルズ・インコーポレイテツド | 舌下またはバッカル投与により送出されるシルデナフィルの制御放出 |
| TWI265925B (en) | 1999-10-11 | 2006-11-11 | Pfizer | Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them |
| CA2391968A1 (en) * | 1999-11-18 | 2001-05-25 | Natco Pharma Limited | An improved pharmaceutical composition for treating male erectile dysfunction |
| DE10010612A1 (de) * | 2000-03-03 | 2001-09-27 | Merck Patent Gmbh | Verwendung von PDE V-Inhibitoren |
| CN1436080A (zh) | 2000-04-19 | 2003-08-13 | 利利艾科斯有限公司 | 环gmp－特异性磷酸二酯酶抑制剂治疗帕金森氏病的用途 |
| WO2002005820A1 (en) * | 2000-07-19 | 2002-01-24 | Lavipharm Laboratories, Inc. | Sildenafil citrate solid dispersions having high water solubility |
| DE10118306A1 (de) * | 2001-04-12 | 2002-10-17 | Bayer Ag | Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation |
| WO2002102385A1 (en) * | 2001-06-14 | 2002-12-27 | Sampad Bhattacharya | Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis |
| AU2003257289A1 (en) | 2002-07-26 | 2004-02-16 | Kenneth W. Adams | Pharmaceutical compositions for penis enlargement |
| US7662831B2 (en) | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
| CN101429166B (zh) * | 2007-11-07 | 2013-08-21 | 上海特化医药科技有限公司 | 喹唑啉酮衍生物及其制备方法和用途 |
| EP2526926A1 (de) * | 2011-05-25 | 2012-11-28 | Justus-Liebig-Universität Gießen | Biokompatible Nanopolymerpartikel mit Wirkstoffen für die pulmonale Applikation |
| RU2618462C2 (ru) * | 2011-12-26 | 2017-05-03 | Тритек Биофармасьютикалз Ко., Лтд. | Способ и улучшенная фармацевтическая композиция для ускорения трансдермальной доставки ингибитора pde-5 |
| US20170035764A1 (en) * | 2015-08-03 | 2017-02-09 | Synergistic Therapeutics, Llc | Sexual dysfunction therapeutic gel |
| JP6865933B2 (ja) | 2018-02-23 | 2021-04-28 | 株式会社Ｍｅｉｓ Ｔｅｃｈｎｏｌｏｇｙ | 勃起不全治療剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9301192D0 (en) * | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
| KR100374924B1 (ko) * | 1994-04-22 | 2003-07-22 | 퀸스 유니버시티 엣 킹스톤 | 남성발기기능장애를회복시키고진단하기위한설하용량형 |
| EP0985671B1 (en) * | 1996-05-31 | 2003-04-02 | Mochida Pharmaceutical Co., Ltd. | PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT |
| GB9612514D0 (en) * | 1996-06-14 | 1996-08-14 | Pfizer Ltd | Novel process |
-
1998
- 1998-05-29 WO PCT/JP1998/002378 patent/WO1998053819A1/ja not_active Application Discontinuation
- 1998-05-29 CN CN98807614A patent/CN1309561A/zh active Pending
- 1998-05-29 BR BR9809508-0A patent/BR9809508A/pt not_active IP Right Cessation
- 1998-05-29 KR KR1019997010967A patent/KR20010012995A/ko not_active Application Discontinuation
- 1998-05-29 EP EP98921878A patent/EP0992240A4/en not_active Withdrawn
- 1998-05-29 AU AU74548/98A patent/AU739417B2/en not_active Ceased
- 1998-05-29 IL IL13299398A patent/IL132993A0/xx unknown
- 1998-05-29 CA CA002291256A patent/CA2291256A1/en not_active Abandoned
-
1999
- 1999-11-26 NO NO995823A patent/NO995823L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010012995A (ko) | 2001-02-26 |
| EP0992240A1 (en) | 2000-04-12 |
| AU7454898A (en) | 1998-12-30 |
| NO995823L (no) | 2000-01-28 |
| CN1309561A (zh) | 2001-08-22 |
| BR9809508A (pt) | 2000-06-20 |
| AU739417B2 (en) | 2001-10-11 |
| EP0992240A4 (en) | 2003-04-16 |
| NO995823D0 (no) | 1999-11-26 |
| CA2291256A1 (en) | 1998-12-03 |
| WO1998053819A1 (fr) | 1998-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL132993A0 (en) | Therapeutic agent for erection failure | |
| GB9725782D0 (en) | Therapeutic agents | |
| GB9708484D0 (en) | Therapeutic agents | |
| GB9718833D0 (en) | Therapeutic agents | |
| GB9708945D0 (en) | Therapeutic agents | |
| GB9704948D0 (en) | Therapeutic agents | |
| GB9702524D0 (en) | Therapeutic agents | |
| GB9711753D0 (en) | Therapeutic agents | |
| GB9713707D0 (en) | Therapeutic agents | |
| GB9715977D0 (en) | Therapeutic agents | |
| GB9711114D0 (en) | Therapeutic agents | |
| HUP0300615A3 (en) | Therapeutic agents | |
| GB9723544D0 (en) | Therapeutic agents | |
| GB9702392D0 (en) | Therapeutic agents | |
| SG106561A1 (en) | Therapeutic agents for macromolecular structures | |
| GB9700555D0 (en) | Therapeutic agents | |
| GB9725126D0 (en) | Therapeutic agents | |
| GB9716463D0 (en) | Therapeutic agents | |
| GB9718254D0 (en) | Therapeutic agents | |
| GB9716457D0 (en) | Therapeutic agents | |
| GB9717299D0 (en) | Therapeutic agents | |
| GB9717097D0 (en) | Therapeutic agents | |
| GB9708406D0 (en) | Therapeutic agents | |
| GB9710743D0 (en) | Therapeutic agents | |
| GB9710745D0 (en) | Therapeutic agents |